XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Reverse Recapitalization - Narrative (Details)
 1 Months Ended
Jun. 09, 2021
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
Mar. 31, 2022
shares
Dec. 31, 2021
shares
Jun. 08, 2021
shares
Schedule Of Reverse Recapitalization [Line Items]          
Stock converted, value, reverse recapitalization $ 900,000,000        
Recapitalization exchange ratio, per share (in dollars per share) | $ / shares $ 10.00        
Recapitalization exchange ratio 3.6281   3.6281    
Common stock, shares outstanding (in shares) | shares 124,045,255   124,456,653 124,303,083  
Stock converted, reverse recapitalization (in shares) | shares 85,324,118        
Equity value $ 900,000,000        
Stock options issued and outstanding (in shares) | shares 7,106,767   9,971,247 8,550,076  
Net proceeds from reverse recapitalization and PIPE financing $ 335,400,000        
Cash acquired through reverse recapitalization 135,400,000        
Reverse recapitalization, cash paid to shareholders 10,100,000        
Gross proceeds from private placement 200,000,000        
Payments of transaction costs $ 8,100,000 $ 18,200,000      
Private Placement          
Schedule Of Reverse Recapitalization [Line Items]          
Shares issued in transaction (in shares) | shares 20,000,000        
Consideration received on transaction $ 200,000,000        
Arya Sciences Acquisition Corp III          
Schedule Of Reverse Recapitalization [Line Items]          
Common stock, shares outstanding (in shares) | shares 18,721,137       19,186,500
Options          
Schedule Of Reverse Recapitalization [Line Items]          
Stock converted, value, reverse recapitalization $ 24,300,000